Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Investigative Ophthalmology & Visual Science|April 3, 2024
Drug Distribution After Intravitreal Injection: A Mathematical ModelAlessia Ruffini, Alessia Casalucci, Caterina Cara, et al.
Investigative Ophthalmology & Visual Science|September 10, 2024
A Mathematical Model of Interstitial Fluid Flow and Retinal Tissue Deformation in Macular EdemaAlessia Ruffini, Mariia Dvoriashyna, Andrea Govetto, et al.
Hematological Oncology|November 20, 2020
Gene expression profile unveils diverse biological effect of serum vitamin D in Hodgkin's and diffuse large B-cell lymphomaBenedetta Donati, Angela Ferrari, Alessia Ruffini, et al.
Hematological Oncology|May 23, 2022
Prognostic value of lesion dissemination in doxorubicin, bleomycin, vinblastine, and dacarbazine-treated, interimPET-negative classical Hodgkin Lymphoma patients: A radio-genomic studyRexhep Durmo, Benedetta Donati, Louis Rebaud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2019
A Gene Expression-based Model to Predict Metabolic Response After Two Courses of ABVD in Hodgkin Lymphoma PatientsStefano Luminari, Benedetta Donati, Massimiliano Casali, et al.
Frontiers in Oncology|August 3, 2023
Incidence, mortality, and survival of hematological malignancies in Northern Italian patients: an update to 2020Lucia Mangone, Domenico Penna, Francesco Marinelli, et al.
Haematologica|June 29, 2023
Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphomaValentina Mularoni, Benedetta Donati, Annalisa Tameni, et al.
Haematologica|May 12, 2018
Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: a phase II multicenter study of the <i>Fondazione Italiana Linfomi</i>Sergio Storti, Michele Spina, Emanuela Anna Pesce, et al.
Pageof 1